Horm Metab Res 1977; 9(5): 394-400
DOI: 10.1055/s-0028-1093489
Originals

© Georg Thieme Verlag KG Stuttgart · New York

Antibody Binding of Thyroid Hormone in Juvenile Goitrous Hypothyroidism

J.  Herrmann , K. H. Rudorff , H.  Kroner , B. N. Premachandra
  • Med. Universitätsklinik and Instut für physiologische Chemie, University of Düsseldorf, Germany and Veterans Administration Hospital, Jefferson Barracks, and Washington University, St. Louis, Missouri, U.S.A.
Further Information

Publication History

Publication Date:
23 December 2008 (online)

Abstract

Serum thyroxine (T4) and triiodothyronine (T3) concentrations by RIA were undetectable in a 14 year old hypothyroid girl who had goiter. Hormone dysgenesis was suspected in this patient and she was treated with T4. Although the clinical hypothyroid state improved towards normal, T4 and T3 values by RIA were consistently low. To clarify the discrepancy between laboratory and clinical diagnosis, T4 concentration in serum was determined by non-RIA competitive protein displacement assay in the ethanol extract of the patient's serum. The value noted was 12.6 µg/100 ml and was consistent with the euthyroid state of T4 treated patient. Prompted by these findings, the patient's serum was further subjected to serologic and electrophoretic analysis for screening anomalous T4 binding proteins. A T4 binding immunoglobulin in patient's serum was detected, while the serologic tests revealed a low thyroglobulin antibody titer. The antibody had high specificity for T4 but not for T3 and other thyroid analogues as noted in inhibition experiments. The electrophoretic observations demonstrating gamma globulinthyroxine interaction were consistent with that noted in an RIA system (using barbital and ANS) where antibody-tracer thyroxine binding curves were examined at various dilutions of patient's serum. The gradually increasing frequency of reports demonstrating gamma globulin interaction of thyroid hormone in thyroid diseases, stresses the need for setting up appropriate thyroid hormone assay controls to detect anomalous T4 and T3 binding proteins in serum in order to avoid erroneous laboratory and clinical diagnosis.